Global Interventional Oncology Market, By Product (Embolization Devices, Ablation Devices, Support Devices), Procedure (Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization, Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy, Transcatheter Arterial Embolization/Bland Embolization), Application (Liver Cancer, Lung Cancer, Breast Cancer, Prostate Cancer, Kidney Cancer, Bone Metastasis, Others), End User (Hospital, Ambulatory Care Centers, Research and Academia), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights : Global Interventional Oncology Market
Interventional oncology market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 3,434.36 million by 2028 growing at a CAGR of 6.89% in the above-mentioned forecast period. The growing awareness amongst the physicians and patients regarding the benefits of interventional oncology which will further create lucrative opportunities for the growth of the market.
Interventional oncology deals with the diagnosis and treatment of cancer using techniques that are minimally invasive and conducted under image guidance. Interventional oncology is used to treat cancer of the liver, kidney cancer, lung cancer, bone cancer, prostate cancer, breast cancer, and pancreatic cancer of the main or metastatic type. Procedures are conducted using guideline accessories and equipment, including ablation electrodes, needles for biopsy and intravascular catheters, to treat a tumour found in remote areas of the body.
Surging volume of patients suffering from breast, liver, lung and other cancer, increasing preferences towards the minimally invasive procedures, increasing prevalence of geriatric and target population, growing levels of public-private funding and government support for interventional oncology, increasing number of technological advancements are some of the major as well as vital factors which will likely to augment the growth of the interventional oncology market in the projected timeframe of 2021-2028. On the other hand, rising number of applications from emerging economies along with increasing number of hospitals which will further contribute by generating massive opportunities that will lead to the growth of the interventional oncology market in the above mentioned projected timeframe.
Lack of skilled and well-trained radiologists and oncologists along with unfavourable regulations of the government which will likely to act as market restraints factor for the growth of the interventional oncology in the above mentioned projected timeframe. Limited clinical data to support therapeutic efficacy along with prevalence of alternative therapies which will become the biggest and foremost challenge for the growth of the market.
This interventional oncology market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on interventional oncology market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Interventional Oncology Market Scope and Market Size
Interventional oncology market is segmented on the basis of product, procedure, application and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on product, the interventional oncology market is segmented into embolization devices, ablation devices, and support devices. Embolization devices have been further segmented into radioembolic agents, and non-radioactive embolic agents. Ablation devices have been further segmented into radiofrequency (RF) ablation devices, microwave ablation devices, cryoablation devices, and other ablation devices. Support devices have been further segmented into microcatheters, and guidewires.
- Interventional oncology market has also been segmented based on the end user into hospital, ambulatory care centers, and research and academia.
- Based on procedure, the interventional oncology market is segmented into thermal tumor ablation, non-thermal tumor ablation, transcatheter arterial chemoembolization, transcatheter arterial radioembolization/selective internal radiation therapy, transcatheter arterial embolization/bland embolization.
- On the basis of application, the interventional oncology market is segmented into liver cancer, lung cancer, breast cancer, prostate cancer, kidney cancer, bone metastasis, and others.
Interventional Oncology Market Country Level Analysis
Interventional oncology market is analysed and market size insights and trends are provided by country, product, procedure, application and end user as referenced above.
The countries covered in the interventional oncology market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the interventional oncology market due to the growing number of technological advancement in the healthcare sector in the region, while Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2021 to 2028 due to the government initiatives towards the development of healthcare facilities, rising incidence and prevalence of cancer; rising awareness towards overall health and treatment availability.
The country section of the interventional oncology market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
Interventional oncology market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for interventional oncology market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the interventional oncology market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Interventional Oncology Market Share Analysis
Interventional oncology market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to interventional oncology market.
The major players covered in the interventional oncology market report are HealthTronics, Inc.; Trod Medical; Sanarus; Teleflex Incorporated.; IMBIOTECHNOLOGIES LTD.; MedWaves, Inc.; IceCure Medical Ltd; Terumo Europe NV; Medtronic; Boston Scientific Corporation; Johnson & Johnson Services, Inc.; Merit Medical Systems; AngioDynamics; Cook; BD.; Profound Medical; EDAP TMS; Sirtex SIR-Spheres Pty Ltd.; Accuray Incorporated; Siemens Healthcare GmbH; among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-